Back to search

Article

Systematic Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma

2023-11-17

Abstract excerpt

<h4>Background: </h4> Lung adenocarcinoma (LUAD) is the most common histological subtype of lung cancer and the leading cause of cancer-related deaths. Identifying novel drug targets for LUAD is essential, with the proteome serving as a major source of therapeutic targets. We performed proteomo-wide Mendelian randomization (MR) and colocalization analyses to identify potential targets for LUAD. <h4>Methods: </h4>...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bca5006b-8f25-5c60-bf8e-69849166b77e
DOI
10.21203/rs.3.rs-3583683/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Systematic Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinomaDOI 10.21203/rs.3.rs-3583683/v1
Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma.Semantic proximity
Identification of promising lung cancer drug targets from human plasma proteins: Mendelian randomization, single-cell RNA sequencing analysisSemantic proximity
Therapeutic targets for lung cancer: genome-wide Mendelian randomization and colocalization analysesSemantic proximity
Identifying new biomarkers and potential therapeutic targets for breast cancer through the integration of human plasma proteomics: a Mendelian randomization study and colocalization analysis.Semantic proximity
Identification of Emerging Drug Targets for Pulmonary Functions Through Mendelian Randomization Analysis of the Plasma ProteomeSemantic proximity
Integration of lung tissue proteomics and genome-wide association data to identify lung cancer susceptibility proteins and potential drug targetsSemantic proximity
Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for lung cancer.Semantic proximity
Potential drug targets for tumors identified through Mendelian randomization analysis.Semantic proximity
Plasma proteometabolome in lung cancer: exploring biomarkers through bidirectional Mendelian randomization and colocalization analysisSemantic proximity
Assessing the Causal Impact of the Circulating Proteome on Susceptibility to Gastrointestinal Cancer-Associated CharacteristicsSemantic proximity
Proteome-wide Mendelian randomization analyses to identify potential therapeutic targets for lung function and respiratory diseaseSemantic proximity
Exploring the cross-cancer effect of circulating proteins and discovering potential intervention targets for 13 site-specific cancers.Semantic proximity
Select a neighboring publication to make it the new centre.